Literature DB >> 32629276

Diaryl disulfides and thiosulfonates as combretastatin A-4 analogues: Synthesis, cytotoxicity and antitubulin activity.

Rejane Gonçalves Diniz Khodyuk1, Ruoli Bai2, Ernest Hamel2, Estela Mariana Guimarães Lourenço1, Euzébio Guimarães Barbosa3, Adilson Beatriz1, Edson Dos Anjos Dos Santos4, Dênis Pires de Lima5.   

Abstract

Diaryl disulfides and diaryl thiosulfonates were synthesized with the two phenyl rings of all compounds bearing identical halide substituents. Because of structural similarity to the potent antimitotic natural product combretastatin A-4 (CA-4), the compounds were examined for inhibition of tubulin polymerization, and the thiosulfonates were more active than the disulfides. The nine thiosulfonates had IC50 values ranging from 1.2 to 9.1 µM, as compared with 1.3 µM obtained with CA-4. The compounds thus ranged from equipotent with CA-4 to 7-fold less active. The nine disulfides had IC50 values ranging from 1.2 to 5.1 µM, as compared with 0.54 µM obtained with CA-4. The compounds thus ranged from less than half as active as CA-4 to over 9-fold less active. The most active members of each group, 2 g and 3c, in the assembly assay were modeled into the colchicine site. Compound 3c had significant hydrophobic interactions with β-tubulin residues CYS 241 and ALA 250, and its thiosulfonate bridge made a hydrogen bond with β-tubulin residue ASN 258. Compound 2 g had hydrophobic interactions with β-tubulin residues ALA 250, CYS 241 and ALA 254, but there was no significant interaction of the disulfide bridge with tubulin.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Combretastatin A-4; Cytotoxicity; Diaryl disulfides; Diaryl thiosulfonates; Tubulin

Mesh:

Substances:

Year:  2020        PMID: 32629276      PMCID: PMC9348037          DOI: 10.1016/j.bioorg.2020.104017

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.307


  19 in total

Review 1.  Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin.

Authors:  Ernest Hamel
Journal:  Cell Biochem Biophys       Date:  2003       Impact factor: 2.194

Review 2.  Anticancer Activity of Stilbene-Based Derivatives.

Authors:  Barbara De Filippis; Alessandra Ammazzalorso; Marialuigia Fantacuzzi; Letizia Giampietro; Cristina Maccallini; Rosa Amoroso
Journal:  ChemMedChem       Date:  2017-03-28       Impact factor: 3.466

3.  AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.

Authors:  Oleg Trott; Arthur J Olson
Journal:  J Comput Chem       Date:  2010-01-30       Impact factor: 3.376

4.  Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.

Authors:  P Verdier-Pinard; J Y Lai; H D Yoo; J Yu; B Marquez; D G Nagle; M Nambu; J D White; J R Falck; W H Gerwick; B W Day; E Hamel
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

5.  Arylthioindoles, potent inhibitors of tubulin polymerization.

Authors:  Gabriella De Martino; Giuseppe La Regina; Antonio Coluccia; Michael C Edler; Maria Chiara Barbera; Andrea Brancale; Elizabeth Wilcox; Ernest Hamel; Marino Artico; Romano Silvestri
Journal:  J Med Chem       Date:  2004-12-02       Impact factor: 7.446

6.  Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization.

Authors:  M Cushman; D Nagarathnam; D Gopal; A K Chakraborti; C M Lin; E Hamel
Journal:  J Med Chem       Date:  1991-08       Impact factor: 7.446

7.  Synthesis and evaluation of a series of benzylaniline hydrochlorides as potential cytotoxic and antimitotic agents acting by inhibition of tubulin polymerization.

Authors:  M Cushman; H M He; C M Lin; E Hamel
Journal:  J Med Chem       Date:  1993-09-17       Impact factor: 7.446

8.  S-(4-Methoxyphenyl)-4-methoxybenzenesulfonothioate as a Promising Lead Compound for the Development of a Renal Carcinoma Agent.

Authors:  Camilla I Nantes; Ingrid D Pereira; Ruoli Bai; Ernest Hamel; James C Burnett; Rodrigo J de Oliveira; Maria de F C Matos; Adilson Beatriz; Murilo K A Yonekawa; Renata T Perdomo; Dênis P de Lima; Danielle Bogo; Edson Dos A Dos Santos
Journal:  ChemMedChem       Date:  2020-01-16       Impact factor: 3.466

9.  Polysulfurating reagent design for unsymmetrical polysulfide construction.

Authors:  Xiao Xiao; Jiahui Xue; Xuefeng Jiang
Journal:  Nat Commun       Date:  2018-06-06       Impact factor: 14.919

10.  The Cytotoxicity of the Ajoene Analogue BisPMB in WHCO1 Oesophageal Cancer Cells Is Mediated by CHOP/GADD153.

Authors:  Vuyolwethu Siyo; Georgia Schäfer; Roger Hunter; Andriy Grafov; Iryna Grafova; Martin Nieger; Arieh A Katz; M Iqbal Parker; Catherine H Kaschula
Journal:  Molecules       Date:  2017-05-28       Impact factor: 4.411

View more
  2 in total

1.  Imaging-Guided Evaluation of the Novel Small-Molecule Benzosuberene Tubulin-Binding Agent KGP265 as a Potential Therapeutic Agent for Cancer Treatment.

Authors:  Yihang Guo; Honghong Wang; Jeni L Gerberich; Samuel O Odutola; Amanda K Charlton-Sevcik; Maoping Li; Rajendra P Tanpure; Justin K Tidmore; Mary Lynn Trawick; Kevin G Pinney; Ralph P Mason; Li Liu
Journal:  Cancers (Basel)       Date:  2021-09-24       Impact factor: 6.575

2.  Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti‑tubulin tetrahydrothieno[2,3‑c]pyridine derivative and a peptide nucleic acid targeting miR‑221‑3p.

Authors:  Matteo Zurlo; Romeo Romagnoli; Paola Oliva; Jessica Gasparello; Alessia Finotti; Roberto Gambari
Journal:  Int J Oncol       Date:  2021-07-19       Impact factor: 5.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.